KALV
KalVista Pharmaceuticals Inc
Price Chart
Latest Quote
$27.00
Current Price| Open | $26.99 |
| Day High | $27.00 |
| Day Low | $26.98 |
| Volume | 4,262,878 |
Stock Information
| Shares Outstanding | 53.24M |
| Total Debt | $284.31M |
| Cash Equivalents | $285.03M |
| Revenue | $114.48M |
| Net Income | $-135.94M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $1.44B |
| EPS (TTM) | $-3.94 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $1.44B |
| Sales | $114.48M |
| Income | $-135.94M |
| Book/sh | $-0.38 |
| Cash/sh | $5.35 |
| Employees | 275 |
Financial Ratios
| Quick Ratio | 4.97 |
| Current Ratio | 5.17 |
Returns & Margins
| Gross Margin | 51.07% |
| Operating Margin | -57.37% |
| Profit Margin | -118.74% |
Ownership
| Insider Ownership | 1.72% |
| Institutional Ownership | 136.88% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 17.48 |
| P/S | 12.56 |
Analyst Data
| Recommendation | hold |
| Target Price | $27.00 |
Technical Indicators
| SMA20 | $26.88 |
| SMA50 | $24.29 |
| SMA200 | $16.98 |
| RSI | 86.21 |
| ATR | 0.0364 |
| Shares Float | 38.18M |
| Short Float | 14.37% |
| Short Ratio | 0.94 |
| Volatility | -0.11 |
Performance History
| Week | +0.19% |
| Month | +0.75% |
| Quarter | +59.39% |
| 6 Months | +60.14% |
| YTD | +74.64% |
| Year | +100.59% |
| 3 Years | +173.28% |
| 5 Years | -3.85% |
| 10 Years | +214.67% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-12 | $27.00 | 0 |
| 2026-06-11 | $27.00 | 0 |
| 2026-06-10 | $27.00 | 4,272,770 |
| 2026-06-09 | $26.99 | 1,537,918 |
| 2026-06-08 | $26.99 | 1,872,647 |
| 2026-06-05 | $26.95 | 1,834,288 |
| 2026-06-04 | $26.95 | 826,066 |
| 2026-06-03 | $26.95 | 6,431,885 |
| 2026-06-02 | $26.94 | 1,512,056 |
| 2026-06-01 | $26.94 | 2,605,772 |
| 2026-05-29 | $26.87 | 1,332,634 |
| 2026-05-28 | $26.77 | 918,186 |
| 2026-05-27 | $26.79 | 2,466,702 |
| 2026-05-26 | $26.81 | 8,068,131 |
About KalVista Pharmaceuticals Inc
As of June 11, 2026, KalVista Pharmaceuticals, Inc. was taken private. KalVista Pharmaceuticals, Inc. operates as a biopharmaceutical company that develops oral therapies for rare diseases in worldwide markets. It offers sebetralstat, a novel, oral, on-demand treatment for hereditary angioedema (HAE), and an oral Factor XIIa inhibitor program. KalVista Pharmaceuticals, Inc. was formerly known as KalVista Pharmaceuticals Ltd. and changed its name to KalVista Pharmaceuticals, Inc. in November 2016. KalVista Pharmaceuticals, Inc. is headquartered in Framingham, Massachusetts. As of June 11, 2026, KalVista Pharmaceuticals, Inc. operates as a subsidiary of Chiesi Farmaceutici S.p.A.
đ° Latest News
KalVista Pharmaceuticals (KALV) Upgraded to Buy: What Does It Mean for the Stock?
Zacks âĸ 2026-06-04T16:00:02Z
KalVista's (KALV) Chief Development Officer Sells 33,800 Shares for $905,000
Motley Fool âĸ 2026-05-31T16:08:43Z
A Look At KalVista Pharmaceuticals (KALV) Valuation After A Strong Year Of Share Price Gains
Simply Wall St. âĸ 2026-05-10T00:24:18Z
Chiesi widens rare disease portfolio with $1.9bn KalVista buyout
Pharmaceutical Technology âĸ 2026-04-30T11:50:11Z
IBT portfolio manager says KalVista deal signals Biotech 2.0 growth
Proactive âĸ 2026-04-30T09:09:29Z
Stock Market Today, April 29: KalVista Pharmaceuticals Surges on Chiesi Group Acquisition Announcement
Motley Fool âĸ 2026-04-29T22:07:49Z
KalVista Scores $1.9 Billion Takeover Deal; Why A Key Rival Jumped Too
Investor's Business Daily âĸ 2026-04-29T20:03:45Z
Sector Update: Health Care Stocks Fall Late Afternoon
MT Newswires âĸ 2026-04-29T19:47:07ZTop Midday Stories: Visa Shares Rise After Strong Q2 Earnings, $20 Billion Buyback Program; Robinhood Misses Q1 EPS, Revenue Targets
MT Newswires âĸ 2026-04-29T15:40:34ZTop Premarket Gainers
MT Newswires âĸ 2026-04-29T12:03:30Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Interest Expense | $5,785,000 | $0 | - | - |
| Total Expenses | $182,981,000 | $131,993,000 | $95,086,000 | $81,310,000 |
| Other Income Expense | $2,279,000 | $1,453,000 | $-53,000 | $-2,119,000 |
| Other Non Operating Income Expenses | $-3,000 | $-10,000 | $-4,000 | $-1,000 |
| Net Non Operating Interest Income Expense | $650,000 | $3,896,000 | $2,232,000 | $1,090,000 |
| Interest Expense Non Operating | $5,785,000 | $0 | - | - |
| Operating Expense | $182,981,000 | $131,993,000 | $95,086,000 | $81,310,000 |
| General And Administrative Expense | $116,286,000 | $54,278,000 | $30,595,000 | $26,446,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-183,444,000 | $-126,644,000 | $-92,907,000 | $-82,339,000 |
| Net Interest Income | $650,000 | $3,896,000 | $2,232,000 | $1,090,000 |
| Interest Income | $6,435,000 | $3,896,000 | $2,232,000 | $1,090,000 |
| Normalized Income | $-185,246,780 | $-128,107,000 | $-92,858,000 | $-80,221,000 |
| Net Income From Continuing And Discontinued Operation | $-183,444,000 | $-126,644,000 | $-92,907,000 | $-82,339,000 |
| Total Operating Income As Reported | $-187,995,000 | $-140,445,000 | $-110,871,000 | $-96,613,000 |
| Net Income Common Stockholders | $-183,444,000 | $-126,644,000 | $-92,907,000 | $-82,339,000 |
| Net Income | $-183,444,000 | $-126,644,000 | $-92,907,000 | $-82,339,000 |
| Net Income Including Noncontrolling Interests | $-183,444,000 | $-126,644,000 | $-92,907,000 | $-82,339,000 |
| Net Income Continuous Operations | $-183,444,000 | $-126,644,000 | $-92,907,000 | $-82,339,000 |
| Pretax Income | $-180,052,000 | $-126,644,000 | $-92,907,000 | $-82,339,000 |
| Interest Income Non Operating | $6,435,000 | $3,896,000 | $2,232,000 | $1,090,000 |
| Operating Income | $-182,981,000 | $-131,993,000 | $-95,086,000 | $-81,310,000 |
| Per Share | ||||
| Diluted EPS | $-3.69 | $-3.44 | $-3.33 | $-3.36 |
| Basic EPS | $-3.69 | $-3.44 | $-3.33 | $-3.36 |
| Other | ||||
| Tax Effect Of Unusual Items | $479,220 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-175,608,000 | $-127,291,000 | $-94,319,000 | $-78,628,000 |
| Total Unusual Items | $2,282,000 | $1,463,000 | $-49,000 | $-2,118,000 |
| Total Unusual Items Excluding Goodwill | $2,282,000 | $1,463,000 | $-49,000 | $-2,118,000 |
| Reconciled Depreciation | $941,000 | $816,000 | $718,000 | $564,000 |
| EBITDA (Bullshit earnings) | $-173,326,000 | $-125,828,000 | $-94,368,000 | $-80,746,000 |
| EBIT | $-174,267,000 | $-126,644,000 | $-95,086,000 | $-81,310,000 |
| Diluted Average Shares | $49,652,878 | $36,786,575 | $27,890,846 | $24,473,092 |
| Basic Average Shares | $49,652,878 | $36,786,575 | $27,890,846 | $24,473,092 |
| Diluted NI Availto Com Stockholders | $-183,444,000 | $-126,644,000 | $-92,907,000 | $-82,339,000 |
| Tax Provision | $3,392,000 | $0 | $0 | $0 |
| Gain On Sale Of Security | $2,282,000 | $1,463,000 | $-49,000 | $-2,118,000 |
| Other Taxes | $-5,014,000 | $-8,452,000 | $-15,785,000 | $-15,303,000 |
| Research And Development | $71,709,000 | $86,167,000 | $80,276,000 | $70,167,000 |
| Selling General And Administration | $116,286,000 | $54,278,000 | $30,595,000 | $26,446,000 |
| Other Gand A | $116,286,000 | $54,278,000 | $30,595,000 | $26,446,000 |
Fetched: 2026-06-11
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2025-04-30 | 2024-04-30 | 2023-04-30 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-2,711,000 | $95,391,000 | $206,582,000 | $161,025,000 |
| Total Assets | $335,375,000 | $250,770,000 | $235,404,000 | $183,202,000 |
| Total Non Current Assets | $15,228,000 | $9,080,000 | $9,714,000 | $10,876,000 |
| Other Non Current Assets | $2,369,000 | $1,548,000 | $567,000 | $106,000 |
| Current Assets | $320,147,000 | $241,690,000 | $225,690,000 | $172,326,000 |
| Prepaid Assets | $5,203,000 | $5,932,000 | $4,418,000 | $4,307,000 |
| Inventory | $3,428,000 | $0 | $0 | - |
| Receivables | $11,302,000 | $15,141,000 | $10,871,000 | $18,644,000 |
| Taxes Receivable | $7,045,000 | $2,315,000 | $9,462,000 | $17,990,000 |
| Accrued Interest Receivable | $1,664,000 | $1,826,000 | $1,409,000 | $654,000 |
| Accounts Receivable | $2,593,000 | $0 | $0 | - |
| Cash Cash Equivalents And Short Term Investments | $300,214,000 | $220,617,000 | $210,401,000 | $149,375,000 |
| Cash And Cash Equivalents | $229,342,000 | $131,615,000 | $31,789,000 | $56,238,000 |
| Other Receivables | - | $11,000,000 | - | - |
| Other Current Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $151,575,000 | $6,307,000 | $7,317,000 | $8,232,000 |
| Long Term Debt And Capital Lease Obligation | $149,954,000 | $4,330,000 | $6,015,000 | $7,145,000 |
| Long Term Debt | $139,227,000 | - | - | - |
| Current Debt And Capital Lease Obligation | $1,621,000 | $1,977,000 | $1,302,000 | $1,087,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $338,086,000 | $155,379,000 | $28,822,000 | $22,177,000 |
| Total Non Current Liabilities Net Minority Interest | $280,731,000 | $110,212,000 | $6,015,000 | $7,145,000 |
| Non Current Deferred Liabilities | $130,777,000 | $105,882,000 | $0 | - |
| Current Liabilities | $57,355,000 | $45,167,000 | $22,807,000 | $15,032,000 |
| Other Current Liabilities | $13,569,000 | - | - | - |
| Current Deferred Liabilities | $0 | $11,000,000 | $0 | - |
| Payables And Accrued Expenses | $18,931,000 | $16,067,000 | $14,818,000 | $9,738,000 |
| Interest Payable | $1,207,000 | $0 | $0 | - |
| Payables | $8,268,000 | $4,883,000 | $9,107,000 | $4,817,000 |
| Accounts Payable | $8,268,000 | $4,883,000 | $9,107,000 | $4,817,000 |
| Equity | ||||
| Common Stock Equity | $-2,711,000 | $95,391,000 | $206,582,000 | $161,025,000 |
| Total Equity Gross Minority Interest | $-2,711,000 | $95,391,000 | $206,582,000 | $161,025,000 |
| Stockholders Equity | $-2,711,000 | $95,391,000 | $206,582,000 | $161,025,000 |
| Gains Losses Not Affecting Retained Earnings | $-7,129,000 | $-5,214,000 | $-3,488,000 | $-3,060,000 |
| Retained Earnings | $-762,694,000 | $-653,170,000 | $-469,726,000 | $-343,082,000 |
| Other Equity Adjustments | - | $-5,214,000 | $-3,488,000 | $-3,060,000 |
| Other | ||||
| Ordinary Shares Number | $50,900,777 | $49,762,048 | $42,521,975 | $34,171,138 |
| Share Issued | $50,900,777 | $49,762,048 | $42,521,975 | $34,171,138 |
| Tangible Book Value | $-2,711,000 | $95,391,000 | $206,582,000 | $161,025,000 |
| Invested Capital | $136,516,000 | $95,391,000 | $206,582,000 | $161,025,000 |
| Working Capital | $262,792,000 | $196,523,000 | $202,883,000 | $157,294,000 |
| Capital Lease Obligations | $12,348,000 | $6,307,000 | $7,317,000 | $8,232,000 |
| Total Capitalization | $136,516,000 | $95,391,000 | $206,582,000 | $161,025,000 |
| Additional Paid In Capital | $767,061,000 | $753,725,000 | $679,754,000 | $507,133,000 |
| Capital Stock | $51,000 | $50,000 | $42,000 | $34,000 |
| Common Stock | $51,000 | $50,000 | $42,000 | $34,000 |
| Non Current Deferred Revenue | $11,714,000 | $0 | $0 | - |
| Long Term Capital Lease Obligation | $10,727,000 | $4,330,000 | $6,015,000 | $7,145,000 |
| Current Deferred Revenue | $0 | $11,000,000 | $0 | - |
| Current Capital Lease Obligation | $1,621,000 | $1,977,000 | $1,302,000 | $1,087,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $18,482,000 | $16,123,000 | $6,687,000 | $4,207,000 |
| Current Provisions | $4,752,000 | - | - | - |
| Current Accrued Expenses | $10,663,000 | $11,184,000 | $5,711,000 | $4,921,000 |
| Net PPE | $12,859,000 | $7,532,000 | $9,147,000 | $10,770,000 |
| Accumulated Depreciation | $-5,374,000 | $-4,747,000 | $-3,712,000 | $-2,958,000 |
| Gross PPE | $18,233,000 | $12,279,000 | $12,859,000 | $13,728,000 |
| Leases | $3,454,000 | $3,091,000 | $2,859,000 | $2,855,000 |
| Other Properties | $12,691,000 | $8,204,000 | $9,329,000 | $10,226,000 |
| Machinery Furniture Equipment | $2,088,000 | $984,000 | $671,000 | $647,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $374,000 | $0 | $0 | - |
| Work In Process | $529,000 | $0 | $0 | - |
| Raw Materials | $2,525,000 | $0 | $0 | - |
| Other Short Term Investments | $70,872,000 | $89,002,000 | $178,612,000 | $93,137,000 |
| Treasury Shares Number | - | - | $0 | - |
Fetched: 2026-06-11
Cash Flow Statement (Annual)
| Metric | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-153,836,000 | $-89,674,000 | $-76,457,000 | $-79,065,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-152,907,000 | $-89,231,000 | $-75,261,000 | $-78,134,000 |
| Cash Flow From Continuing Operating Activities | $-152,907,000 | $-89,231,000 | $-75,261,000 | $-78,134,000 |
| Operating Gains Losses | $-3,986,000 | $-565,000 | $-1,479,000 | $2,133,000 |
| Investing Activities | ||||
| Capital Expenditure | $-929,000 | $-443,000 | $-1,196,000 | $-931,000 |
| Investing Cash Flow | $91,024,000 | $-84,719,000 | $41,415,000 | $57,860,000 |
| Cash Flow From Continuing Investing Activities | $91,024,000 | $-84,719,000 | $41,415,000 | $57,860,000 |
| Capital Expenditure Reported | $-495,000 | $-401,000 | $0 | $0 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $55,911,000 | $96,945,000 | $56,582,000 | $0 |
| Financing Cash Flow | $159,727,000 | $150,714,000 | $58,116,000 | $1,581,000 |
| Cash Flow From Continuing Financing Activities | $159,727,000 | $150,714,000 | $58,116,000 | $1,581,000 |
| Net Other Financing Charges | $98,040,000 | - | - | - |
| Net Common Stock Issuance | $55,911,000 | $96,945,000 | $56,582,000 | $0 |
| Common Stock Issuance | $55,911,000 | $96,945,000 | $56,582,000 | $0 |
| Other | ||||
| End Cash Position | $132,272,000 | $31,789,000 | $56,238,000 | $30,732,000 |
| Beginning Cash Position | $31,789,000 | $56,238,000 | $30,732,000 | $50,592,000 |
| Effect Of Exchange Rate Changes | $2,639,000 | $-1,213,000 | $1,236,000 | $-1,167,000 |
| Changes In Cash | $97,844,000 | $-23,236,000 | $24,270,000 | $-18,693,000 |
| Proceeds From Stock Option Exercised | $5,776,000 | $53,769,000 | $1,534,000 | $1,581,000 |
| Net Investment Purchase And Sale | $91,953,000 | $-84,276,000 | $42,611,000 | $58,791,000 |
| Sale Of Investment | $122,524,000 | $104,955,000 | $140,857,000 | $195,711,000 |
| Purchase Of Investment | $-30,571,000 | $-189,231,000 | $-98,246,000 | $-136,920,000 |
| Net PPE Purchase And Sale | $-434,000 | $-42,000 | $-1,196,000 | $-931,000 |
| Purchase Of PPE | $-434,000 | $-42,000 | $-1,196,000 | $-931,000 |
| Change In Working Capital | $15,035,000 | $15,167,000 | $7,413,000 | $-12,322,000 |
| Change In Other Working Capital | $10,558,000 | - | - | - |
| Change In Payables And Accrued Expense | $9,458,000 | $7,529,000 | $3,039,000 | $2,159,000 |
| Change In Accrued Expense | $14,429,000 | $3,209,000 | $1,932,000 | $472,000 |
| Change In Payable | $-4,971,000 | $4,320,000 | $1,107,000 | $1,687,000 |
| Change In Account Payable | $-4,971,000 | $4,320,000 | $1,107,000 | $1,687,000 |
| Change In Prepaid Assets | $-1,358,000 | $-538,000 | $6,690,000 | $-9,280,000 |
| Change In Receivables | $-3,623,000 | $8,176,000 | $-2,316,000 | $-5,201,000 |
| Other Non Cash Items | $6,242,000 | $-12,000 | $84,000 | $179,000 |
| Stock Based Compensation | $12,291,000 | $21,915,000 | $9,922,000 | $11,086,000 |
| Amortization Of Securities | $14,000 | $92,000 | $988,000 | $2,565,000 |
| Depreciation Amortization Depletion | $941,000 | $816,000 | $718,000 | $564,000 |
| Depreciation And Amortization | $941,000 | $816,000 | $718,000 | $564,000 |
| Gain Loss On Investment Securities | $189,000 | $-1,325,000 | $139,000 | $581,000 |
| Net Foreign Currency Exchange Gain Loss | $-4,175,000 | $760,000 | $-1,618,000 | $1,552,000 |
| Net Income From Continuing Operations | $-183,444,000 | $-126,644,000 | $-92,907,000 | $-82,339,000 |
| Repayment Of Debt | - | - | - | $0 |
| Net Issuance Payments Of Debt | - | - | - | $0 |
| Net Long Term Debt Issuance | - | - | - | $0 |
| Long Term Debt Payments | - | - | - | $0 |
| Change In Other Current Assets | - | - | - | - |
Fetched: 2026-06-11